COVID-19 vaccines: Knowing the unknown

被引:21
|
作者
Lv, Huibin [1 ]
Wu, Nicholas C. [2 ]
Mok, Chris K. P. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China
[2] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
基金
中国国家自然科学基金; 美国国家卫生研究院;
关键词
COVID-19; SARS-CoV-2; Vaccine; ANTIBODY-DEPENDENT ENHANCEMENT; DESIGN; NEUTRALIZATION; PROTECTION; INFECTION; IMMUNITY; SAFETY; VIRUS;
D O I
10.1002/eji.202048663
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccine development against SARS-CoV-2 has drawn attention around the globe due to the exploding pandemic. Although COVID-19 is caused by a new coronavirus, SARS-CoV-2, previous research on other coronavirus vaccines, such as FIPV, SARS, and MERS, has provided valuable information for the rapid development of COVID-19 vaccine. However, important knowledge gaps remain - some are specific to SARS-CoV-2, others are fundamental to immunology and vaccinology. Here, we discuss areas that need to be addressed for COVID-19 vaccine development, and what can be learned from examples of vaccine development in the past. Since the beginning of the outbreak, the research progress on COVID-19 has been remarkable. We are therefore optimistic about the rapid development of COVID-19 vaccine.
引用
收藏
页码:939 / 943
页数:5
相关论文
共 50 条
  • [31] Anaphylaxis and COVID-19 vaccines
    Castells, M.
    Demoly, P.
    Tanno, L. K.
    REVUE FRANCAISE D ALLERGOLOGIE, 2021, 61 (08): : S30 - S35
  • [32] Challenges and Recent Advancements in COVID-19 Vaccines
    Wang, Shao-Cheng
    Rai, Chung-, I
    Chen, Yuan-Chuan
    MICROORGANISMS, 2023, 11 (03)
  • [33] COVID-19 vaccines: current and future challenges
    Mohammadi, Davood
    Ghasemi, Matin
    Manouchehrian, Nahid
    Zafarmand, Milad
    Akbari, Mitra
    Boroumand, Amir Bahador
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] Complement Factors in COVID-19 Therapeutics and Vaccines
    Kurtovic, Liriye
    Beeson, James G.
    TRENDS IN IMMUNOLOGY, 2021, 42 (02) : 94 - 103
  • [35] Efficacy of COVID-19 vaccines by race and ethnicity
    Salari, N.
    Vepa, A.
    Daneshkhah, A.
    Darvishi, N.
    Ghasemi, H.
    Khunti, K.
    Mohammadi, M.
    PUBLIC HEALTH, 2022, 208 : 14 - 17
  • [36] Recombinant vaccines for COVID-19
    Yadav, Tushar
    Srivastava, Nishant
    Mishra, Gourav
    Dhama, Kuldeep
    Kumar, Swatantra
    Puri, Bipin
    Saxena, Shailendra K.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (12) : 2905 - 2912
  • [37] COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials
    Yan, Zhi-Peng
    Yang, Ming
    Lai, Ching-Lung
    PHARMACEUTICALS, 2021, 14 (05)
  • [38] COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions
    Khan, Wajihul Hasan
    Hashmi, Zohra
    Goel, Aditya
    Ahmad, Razi
    Gupta, Kanisha
    Khan, Nida
    Alam, Iqbal
    Ahmed, Faheem
    Ansari, Mairaj Ahmed
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [39] Advances in COVID-19 Vaccines and New Coronavirus Variants
    Liu, Mengchen
    Li, Yunqiao
    FRONTIERS IN MEDICINE, 2022, 9
  • [40] Efficacy and Safety of COVID-19 Vaccines-An Update
    Sharma, Eshani
    Revinipati, Sraddha
    Bhandari, Saisha
    Thakur, Sejal
    Goyal, Shubham
    Ghose, Aruni
    Bajpai, Sukrit
    Muhammad, Waleed
    Boussios, Stergios
    DISEASES, 2022, 10 (04)